Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2011
07/06/2011CN102114092A Baicao oil for external use
07/06/2011CN102114082A Compound giant knotweed emulsion for preventing livestock and poultry infection
07/06/2011CN102114064A Externally used medicine for treating thrush and preparation method thereof
07/06/2011CN102114044A Artificially processed bear bile powder and preparation method thereof
07/06/2011CN102114041A Composition for treating fowl cholera and preparation method thereof
07/06/2011CN102114027A Oxygen-driven atomized inhalation solution for infant asthmatic suffocating pneumonia
07/06/2011CN102114026A Ointment preparation for treating duck leg diseases and preparation method thereof
07/06/2011CN102114020A Pharmaceutical composition containing besivance or salts thereof and preparation method thereof
07/06/2011CN102114019A Compound cefaclor preparation and preparation method
07/06/2011CN102114010A Medicinal composition for treating gastrointestinal disorders as well as preparation method and application thereof
07/06/2011CN102113973A Oral cavity disinfecting liquor and production method thereof
07/06/2011CN102113524A Chinese medicinal disinfectant
07/06/2011CN101955915B Method for producing influenza virus vaccine
07/06/2011CN101773569B Oral Chinese medicine liquid for treating chicken infectious laryngotracheitis
07/06/2011CN101773469B Aztreonam/arginine medicament composition suspension injection
07/06/2011CN101721371B Cefetamet pivoxil hydrochloride submicron emulsion solid preparation and new application thereof
07/06/2011CN101708166B Cefpodoxime proxetil submicron emulsion solid preparation and novel application thereof
07/06/2011CN101703549B Atractylone lipidosome and preparation method thereof
07/06/2011CN101693010B Cefathiamidine prosoma liposome preparation
07/06/2011CN101671348B Ceftizoxime sosium compound of new way
07/06/2011CN101653518B Medicinal composition for treating child diarrhea and child infectious diarrhea and preparation method
07/06/2011CN101648991B Small peptide C with antibacterial and antitumor functions and applications thereof
07/06/2011CN101648962B C3/C3 fluoroquinolone dipolymer derivative taking s-triazolo-[3,4-b][1,3,4] thiadiazole as connecting chain and preparation method and application thereof
07/06/2011CN101647936B Manufacture method of mouth care lozenges
07/06/2011CN101612204B Medicament-resistant inhibitor for porcine streptococcus
07/06/2011CN101612175B Separation and identification of syringa amurensis rupr. bark volatile oil components and novel application
07/06/2011CN101585843B Process for preparing rifaximin
07/06/2011CN101579420B External medicine for curing lepriasis old ulcerative-point erosion as well as burns and scalds
07/06/2011CN101560236B Method for synthesizing marine polyhydroxyl sterol (25R)-5alpha -cholest-3 beta, 5alpha, 6beta, 26-tetrol
07/06/2011CN101538327B Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof
07/06/2011CN101444514B Cefmenoxime hydrochloride preparation for injection and preparation method thereof
07/06/2011CN101381365B Dual action antibiotics
07/06/2011CN101304741B Water-soluble antiviral agent based on silver-cistine compound and method of preparing thereof
07/06/2011CN101280326B Preparation and application of compound for inhabiting aspergillus fumigatus activity
07/06/2011CN101239091B Composition for preventing and controlling helicobacter pylori affection
07/06/2011CN101119986B Optically active tetrahydronaphthalene derivative
07/06/2011CN101014572B Carbamoylpyridone derivative having HIV integrase inhibitory activity
07/06/2011CN101007062B Traditional Chinese medicine composition capable of resisting infection
07/05/2011US7973153 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences
07/05/2011US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin
07/05/2011US7973080 Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1,5-diol
07/05/2011US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/05/2011US7973040 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
07/05/2011US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse
07/05/2011US7972843 DNA-transfection system for the generation of infectious influenza virus
07/05/2011US7972814 Antimicrobial polypeptides from Pseudoplectania nigrella
07/05/2011US7972777 Nucleic acid probe-based diagnostic assays targeting ssrA genes of prokaryotic and eukaryotic organisms
07/05/2011US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids
07/05/2011CA2660818C Antibacterial agent and therapeutic agent for johne's disease containing the same
07/05/2011CA2577247C Method for manufacturing enantiomeric imidazole compounds
07/05/2011CA2533434C Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof
07/05/2011CA2504872C Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
07/05/2011CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
07/05/2011CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
07/05/2011CA2459172C Bicyclic compound, production and use thereof
07/05/2011CA2451866C Nutritional composition preventing bacterial overgrowth
07/05/2011CA2446971C Use of 3-position cyclosporin derivatives for hair growth
07/05/2011CA2427475C Purification of hbv antigens for use in vaccines
07/05/2011CA2423279C Phthalazinone derivatives
07/05/2011CA2220133C Recombinant vesiculoviruses and their uses
07/05/2011CA2217745C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/2011
06/30/2011WO2011079327A1 Analogues for the treatment or prevention of flavivirus infections
06/30/2011WO2011079260A2 Stabilized virus like particles having enhanced mucosal immunogenicity
06/30/2011WO2011079249A2 Use of vitamin d glycosides and sulfates for treatment of disease
06/30/2011WO2011079234A2 Highly permeating terbinafine formulation
06/30/2011WO2011079034A1 Extracts from kibdelos porangium as antibacterial agents
06/30/2011WO2011079016A1 Methods of treating hbv and hcv infection
06/30/2011WO2011078820A1 Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid
06/30/2011WO2011078221A1 Imidazopyridazine compounds
06/30/2011WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
06/30/2011WO2011077100A1 Antiretroviral composition
06/30/2011WO2011076923A1 Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e
06/30/2011WO2011076873A1 Influenza targets
06/30/2011WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors
06/30/2011WO2011076765A1 Novel antiviral compounds
06/30/2011WO2011076327A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
06/30/2011WO2011076086A1 Intermediate compounds of tamiflu, methods of preparation and uses thereof
06/30/2011WO2011076048A1 Medical and pharmaceutical use of 2', 2-bis-thiazole non-nucleoside compounds as hepatitis c virus inhibitor
06/30/2011WO2011075823A1 Immunogenic compositions
06/30/2011WO2011075822A1 Immunogenic compositions and related methods
06/30/2011WO2011075766A1 Antimicrobial compounds
06/30/2011WO2011060613A9 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof
06/30/2011WO2011056741A3 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
06/30/2011WO2011038933A3 Anti-hsv antibody
06/30/2011WO2011014008A3 Novel 3-phenoxy-4-pyrone, 3-phenoxy-4-pyridone, or 4-pyridone derivatives, method for preparing same, and antimicrobial composition containing same as an active ingredient
06/30/2011WO2011013992A3 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
06/30/2011WO2011012855A3 Antibacterial combinations comprising a garlic extract or s -allyl cysteine
06/30/2011WO2010150982A3 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same
06/30/2011WO2010117287A3 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition.
06/30/2011US20110162115 Recombinant ndv antigen and uses thereof
06/30/2011US20110162095 TNFSF Single Chain Molecules
06/30/2011US20110160845 Drug delivery system and method of manufacturing thereof
06/30/2011US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
06/30/2011US20110160305 Oral Delivery of Therapeutic Doses of Glutathione
06/30/2011US20110160304 Inhibitors of Yeast Filamentous Growth and Method of Their Manufacture
06/30/2011US20110160289 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
06/30/2011US20110160252 Pharmaceutical compositions for treatment or prevention of hbv infection
06/30/2011US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
06/30/2011US20110160235 Triazolyl tropane derivatives
06/30/2011US20110160233 Anti-viral compounds